4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-20-055716
Options or other derivatives
- President, CEO acquired 804,170 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SANDS ARTHUR T · President, CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-10-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +804,170 | $26.91 | 2030-10-20 | 804,170 | 804,170 | D |
Loading xslF345X03/doc4.xml…